3WHO. Global Tuberculosis Control-surveillance, planning, financing[R]. WHO Report,2007. WPIO/HTM/TB/2007.
4Korenromp E L,Scano F,Williams B G,et al. Effects of hu-man immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment:an analytical review[J], Clin Infect Dis,2003,37(1) :101-112.
5Corgett E L,Watt C J,Walker N,et al. The growing burden of tuber culosis: global trends and interactions with the HIVepidemlc[J]. Arch Intern Med, 2003,163(9) : 1009-1021.
6Raja A. Immunology of tuberculosis[J]. Indian J Med Res, 2004,120(4) :213-232.
7Sharma S K, Mohan A, Kadhiravan T. HIV-TB co-infection: epidemiology,diagnosis and management [J]. Indian J Med Res, 2005,121 (4):550-567.
8Havlir D V,Barnes P F. Tuberculosis in patients with humanimmunodeficiency virus infection[J]. N Engl J Med, 1999,340 (5):367-373.
4CASCADE Collaboration. Impact of Tuberculosis on HIV Disease Progression in Persons With Well-Documented Time of HIV Seroconversion [ J ]. Journal of Acquired Immune Deficiency Syndromes, 2003, 33:184-190.
5Dermot Maher, Anthony Harries, Haileyesus Getahun. Tuberculosis and HIVinteraction in sub-Saharan Africa impact [ J ]. Tropical Medicine and International Health, 2005,10 (8) : 734-742.
6Z. Toossi, H. Mayanja-Kizza, C. S. Hirsch, et al. Impact of tuberculosis (TB)on HIV-1 activity in dually infected patients[J]. Clin Exp Immunol,2001,123 : 233-238.
7Diane V. Havlir, Peter F. Barnes. Tuberculosis in patients with human immunodeficiency virus infection[J ]. The New England Journal of Medicine, 1999,340(5) :367-373.
8Helen McShane. Co-infection with HIV and TB: double trouble[J]. International Journal of STD & AIDS,2005,16:95-101.
9Thomas Sehon, Dawit Wolday, Daniel Elias et al. Kinetics of sedimentation rate,viral load and TNF-alpha in relation to HIV co-infection in tuberculosis[J]. Transactions of the Royal Society of Tropical Medicine and Hygiene,2006,100(5) :483-488.
10Russell S. The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome[J]. Am J Trop Med Hyg,2004,71(Suppl 2) : 147-155.
5Sharma SK,Mohan A,Kadhiravan T.HIV-TBco-infection:epidemiology,diagnosis & management[J].Indian J Med Res,2005,121(4):550-567.
6Sonnenberg P,Glynn JR,Fielding K,et al.HIV and pulmonary uberculosis:the impactgoes beyond those infected with HIV[J].AIDS,2004,18(4):657-562.
7张立兴,叶任高,陆再英.内科学[M].第6版.北京:人民卫生出版社,2005:39-56.
8Piersimoni C,Scarparo C,Callegaro A,et al.Comparison of MB/Bact alert 3D system with radiometric BACTEC system and Lowenstein-Jensenmedium for recovery and identification ofmycobacteria from clinical specimens:a multicenter study[J].J Clin Microbiol,2001,39(2):651-657.
9Saiman L.The mycobacteriology of non-tuberculousm ycobacteria[J].Pae-diatr Respir Rev,2004,5:S221-S223.
10Mandy FF,Nicho]son JK,McDougal JS,et al Guidelines for performing single-platform absolute CD 4+ T cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Controt and Prevention[J].MMW Recomm i%p,2003,31 ,52(BE 2):]-13,,etal HYPEELINK http://www.ncbi.n]m.nih.gov/ pubmed/12583540PS\o"MMWB. Recommendations And reports:Morbidity And mortality weekly report.Recommendations and reports/Centers for Disease Contro].",2003,31,52(RR-2):l 13.
